437
Views
3
CrossRef citations to date
0
Altmetric
Articles

Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides

, , , , &
Pages 1598-1606 | Received 03 Nov 2021, Accepted 06 Feb 2022, Published online: 24 Feb 2022

References

  • Bradford PT, Devesa SS, Anderson WF, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064–6073.
  • Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–3785.
  • Hodak E, Amitay-Laish I, Atzmony L, et al. New insights into folliculotropic mycosis fungoides (FMF): a single-center experience. J Am Acad Dermatol. 2016;75(2):347–355.
  • Kempf W, Ostheeren-Michaelis S, Paulli M, et al. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the cutaneous lymphoma histopathology task force group of the European organization for research and treatment of cancer (EORTC). Arch Dermatol. 2008;144(12):1609–1617.
  • Abbott RA, Sahni D, Robson A, et al. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features. J Am Acad Dermatol. 2011;65(2):313–319.
  • Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/sézary syndrome: validation of the revised international society for cutaneous lymphomas/European organisation for research and treatment of cancer staging proposal. J Clin Oncol. 2010;28(31):4730–4739.
  • Alsaleh QA, Nanda A, Al-Ajmi H, et al. Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991-2006. Int J Dermatol. 2010;49(12):1393–1398.
  • Boulos S, Vaid R, Aladily TN, et al. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients. J Am Acad Dermatol. 2014;71(6):1117–1126.
  • Hodak E, Amitay-Laish I, Feinmesser M, et al. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement. J Am Acad Dermatol. 2014;70(6):993–1001.
  • Pavlovsky L, Mimouni D, Amitay-Laish I, et al. Hyperpigmented mycosis fungoides: an unusual variant of cutaneous T-cell lymphoma with a frequent CD8+ phenotype. J Am Acad Dermatol. 2012;67(1):69–75.
  • Jung JM, Lim DJ, Won CH, et al. Mycosis fungoides in children and adolescents: a systematic review. JAMA Dermatol. 2021;157(4):431–438.
  • Kalay Yildizhan I, Sanli H, Akay BN, et al. CD8+ cytotoxic mycosis fungoides: a retrospective analysis of clinical features and follow-up results of 29 patients. Int J Dermatol. 2020;59(1):127–133.
  • Khader A, Manakkad SP, Shaan M, et al. A clinicopathological analysis of primary cutaneous lymphomas: a 6-year observational study at a tertiary care center of South India. Indian J Dermatol. 2016;61(6):608–617.
  • Schneider B, Vogel A, Zisiadis S, et al. Hyperpigmented small spots induced by long-term PUVA therapy. A clinical, light and electron microscopic study. Dermatologica. 1982;165(4):330–341.
  • Kikuchi A, Shimizu H, Nishikawa T. Mycosis fungoides with marked hyperpigmentation. Dermatology. 1996;192(4):360–363.
  • Balić A, Jerković Gulin S, Čeović R, et al. Hyperpigmented mycosis fungoides: a rare entity. Acta Dermatovenerol Croat. 2019;27(2):131–132.
  • David M, Shanon A, Hazaz B, et al. Diffuse, progressive hyperpigmentation: an unusual skin manifestation of mycosis fungoides. J Am Acad Dermatol. 1987;16(1 Pt 2):257–260.
  • Price NM. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration. Arch Dermatol. 1977;113(10):1387–1389.
  • Olsen E, Vonderheid E, Pimpinelli N, ISCL/EORTC, et al. Revisions to the staging and classification of mycosis fungoides and sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713–1722.
  • Stawiski MA. Skin manifestations of leukemias and lymphomas. Cutis. 1978;21(6):814–818.
  • Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore). 1980;59(4):311–322.
  • Yamamoto T, Katayama I, Nishioka K. Role of mast cell and stem cell factor in hyperpigmented mycosis fungoides. Blood. 1997;90(3):1338–1340.
  • Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med. 1996;183(6):2681–2686.
  • Barnhill RL, Braverman IM. Progression of pigmented purpura-like eruptions to mycosis fungoides: report of three cases. J Am Acad Dermatol. 1988;19(1):25–31.
  • Erbil H, Sezer E, Koseoglu D, et al. Hyperpigmented mycosis fungoides: a case report. J Eur Acad Dermatol Venereol. 2007;21(7):982–983.
  • Dummer R, Kamarashev J, Kempf W, et al. Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? Arch Dermatol. 2002;138(2):199–203.
  • Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 6 ½-year follow-up of 9 patients. J Am Acad Dermatol. 2000;42(1):33–39.
  • Stone ML, Styles AR, Cockerell CJ, et al. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis. 2001;67(2):133–138.
  • Puig L, Musulén E, Fernández-Figueras MT, et al. Mycosis fungoides associated with unusual epidermal hyperplasia. Clin Exp Dermatol. 1996;21(1):61–64.
  • Rodney IJ, Kindred C, Angra K, et al. Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study. J Eur Acad Dermatol Venereol. 2017;31(5):808–814.
  • Koorse S, Tirumalae R, Yeliur IK, et al. Clinicopathologic profile of hypopigmented mycosis fungoides in India. Am J Dermatopathol. 2012;34(2):161–164.
  • Khopkar U, Doshi BR, Dongre AM, et al. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides. Indian J Dermatol Venereol Leprol. 2011;77(2):167–173.
  • El-Shabrawi-Caelen L, Cerroni L, Medeiros LJ, et al. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol. 2002;26(4):450–457.
  • Kondo M, Igawa K, Munetsugu T, et al. Increasing numbers of mast cells in skin lesions of hyperpigmented mycosis fungoides with large-cell transformation. Ann Dermatol. 2016;28(1):115–116.
  • Soughi M, Mernissi FZ. Hyperpigmented mycosis fungoides: a rare variant. Pan Afr Med J. 2013;15:13.
  • Lu YY, Wu CH, Lu CC, et al. Hyperpigmentation as a peculiar presentation of mycosis fungoides. An Bras Dermatol. 2017;92(5 Suppl 1):92–94.
  • Hodak E, David M, Maron L, et al. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. J Am Acad Dermatol. 2006;55(2):276–284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.